Glenmark Life Sciences (GLS) is a generic API (Active Pharmaceutical Ingredients) manufacturer and a subsidiary of Glenmark Pharmaceuticals. The Glenmark Life Sciences IPO is worth Rs. 1,514 crore, comprising fresh issue of Rs.1,060 crore and an offer for sale worth Rs.454 crore by Glenmark Pharmaceuticals. Should you invest in the IPO of this high-value, non-commoditized API player?
Zero in on the right stocks at the right time
No more tall claims or frivolous guarantees.
Only quality, long-term growth.
Get expert help to build a complete suite of great investments.
Stay on top of your investments
Deep-dive into lesser-known stocks
Get buy calls, at the right time & right price
Receive alerts on booking profits or selling
Get a heads up on stocks in our watchlist
Use smart filters for DIY investing decisions
An FMCG promise
This stock’s potential hinges on FMCG growth, and gets the same ‘defensive’ tag that FMCG does. But, unlike FMCGs, it doesn’t trade at multi-year highs.
A solid NBFC
This company ticks every box – a great customer market, access to low-cost funding, comfortable capital cushion, well-provisioned for potential NPAs, and reasonable valuations
A power play
This stock wins on superior margins, pricing power, and vast retail market access. All this with great valuations and steady dividends providing a moat.
What we offer
Looking to buy investment-friendly stocks that come with long-term payoffs? Prime Stocks provides an expertly-curated list of stocks from which you can choose.
We also provide real-time updates on our coverage and when to accumulate, book profits or sell.
DIY stock filters (with download features)
Been in the game long enough to know what you are looking for? Prefer to do your own research? Prime Stocks puts you in the driver’s seat.
Our stock screener tool lets you do your own stock analysis with the right evaluation metrics and data.
Predesigned stock screeners
Want to do your own analysis but don’t quite know where to start? Or looking for unique filters like steady dividend payouts or rising profits or higher FII holding?
Our pre-built screeners give you a great base and it’s easy for you to add on other different filters for a great shortlist.
New stock opportunities
Eager to unearth lesser-known stocks that can turn out to be hidden gems? We dive deep into stock performers and numbers to review lesser-known or up-and-coming stocks.
Our in-depth analysis and data on stocks will keep you two steps ahead and keep you informed on all that’s going on in the world of stocks.
Make each investment take you one step closer to achieving your financial goals
with stock recommendations, reviews & filtering tools
model with advanced metrics to measure stock strength & growth
on shortlisted stocks to pick the best of long-term potential
on recommended stocks – hold, book profits or sell at the right time
Feature-rich screener tool
with filters and metrics that aren’t easily available like NPAs or cash flow growth
on standalone/ consolidated financials, prices, past valuations & more
Why our customers trust us
Get expertly-curated stock recommendations
Our latest insights
There are certain characteristics which make evaluating banking and finance stocks different from others which produce goods and services. Money cannot be lent to someone unless there is an inflow by way of capital or debt. Since it is not practical to lend only from capital, borrowing (or leverage) is the sustaining food for this business. Naturally in using this leverage, there are good and bad apples.
Amara Raja Batteries Limited (ARBL) is the second largest storage battery manufacturer in India by revenue. The organised sector is a duopoly structure with two major players, ARBL and Exide Industries.
Frequently Asked Questions
Prime Stocks is purely for long-term investors who want to supplement their portfolio of mutual funds, deposits, or ETFs with quality stocks. It is not meant for active stock-only investors who wish to have frequent ‘buy’ or ‘reduce’ calls.
We do not provide any target price for our stocks as we think they are meant for long-term holding. However, in case of any valuations that may be out of sync with growth prospects or other governance or regulatory risks, we will issue a sell call or even ‘book profits’ calls.
We also do not use any technical analysis to pick Prime stocks.
This is not an advisory service. Hence, we will not provide any advice on your stock holdings or
We will respond only to queries relating to the recommendations in our list. We will not respond to individual stock queries. We also retain the discretion to review stocks that we find worthy and do not cover stocks on your request.
Our filters and screeners are not our recommendations. They are tools meant for your analysis. We do not provide any research on screeners that you run.
We do not guarantee any returns on stocks that we recommend and are not liable for any losses you may incur based on the recommendations.
We do not have any platform to provide any execution service. We also do not manage your money in any form.